2020 annual financial data
Immunovant, Inc. 2020 Operating margin
Immunovant, Inc. 2020 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -59,678,000 USD and net income was -66,388,000 USD.
Operating cash flow was -53,357,000 USD.
Get free Immunovant, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -59,678,000 USD
- Net income
- -66,388,000 USD
- Operating cash flow
- -53,357,000 USD